Total Payments
$10,538
2024 Payments
$60.35
Companies
43
Transactions
288
Medicare Patients
12,510
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$7,368 (69.9%)
Travel$2,604 (24.7%)
Education$566.25 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,368 | 262 | 69.9% |
| Travel and Lodging | $2,604 | 12 | 24.7% |
| Education | $566.25 | 14 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,434 | 46 | $0 (2023) |
| Coloplast Corp | $1,550 | 24 | $0 (2022) |
| Ethicon US, LLC | $1,248 | 42 | $0 (2022) |
| Astellas Pharma US Inc | $876.19 | 34 | $0 (2022) |
| NeoTract Inc. | $785.34 | 17 | $0 (2020) |
| Medtronic USA, Inc. | $579.93 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $492.82 | 18 | $0 (2022) |
| Teleflex LLC | $299.72 | 9 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $293.24 | 10 | $0 (2022) |
| Axonics, Inc. | $199.07 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.35 | 3 | Sumitomo Pharma America, Inc. ($60.35) |
| 2023 | $179.39 | 4 | Axonics, Inc. ($134.28) |
| 2022 | $755.41 | 31 | Teleflex LLC ($180.60) |
| 2021 | $1,329 | 49 | Janssen Biotech, Inc. ($354.50) |
| 2020 | $908.12 | 40 | Boston Scientific Corporation ($226.47) |
| 2019 | $4,762 | 79 | Boston Scientific Corporation ($1,745) |
| 2018 | $1,423 | 45 | Ethicon US, LLC ($540.02) |
| 2017 | $1,121 | 37 | Ethicon US, LLC ($293.19) |
All Payment Transactions
288 individual payment records from CMS Open Payments — Page 2 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: Urology | ||||||
| 03/08/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: UROLOGY | ||||||
| 03/03/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Interventional Urology | ||||||
| 02/17/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Urology | ||||||
| 02/14/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 02/12/2022 | Ethicon US, LLC | Harmonic (Device) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Energy | ||||||
| 02/09/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Oncology | ||||||
| 01/31/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: UROLOGY | ||||||
| 01/26/2022 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Medical Systems | ||||||
| 01/24/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Urology | ||||||
| 01/13/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Continence Care | ||||||
| 01/12/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: UROLOGY | ||||||
| 12/16/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $23.09 | General |
| Category: Urology | ||||||
| 12/13/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $93.90 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/23/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Oncology | ||||||
| 11/15/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $90.00 | General |
| Category: Oncology | ||||||
| 11/10/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/03/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Oncology | ||||||
| 10/06/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 09/23/2021 | 180 Medical, Inc. | GentleCath (Device) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Continence Care | ||||||
| 09/22/2021 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Oncology | ||||||
| 09/21/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $51.23 | General |
| Category: Oncology | ||||||
| 09/20/2021 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 200 | 231 | $30,997 | $14,116 |
| 2022 | 42 | 4,288 | 8,408 | $1.7M | $414,151 |
| 2021 | 36 | 4,637 | 7,720 | $2.1M | $497,688 |
| 2020 | 30 | 3,385 | 5,259 | $1.8M | $387,297 |
Total Patients
12,510
Total Services
21,618
Medicare Billing
$1.3M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 65 | $13,910 | $6,361 | 45.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 15 | 15 | $4,980 | $2,737 | 55.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,600 | $2,540 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $4,350 | $2,160 | 49.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 62 | 83 | $581.00 | $176.00 | 30.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 18 | 18 | $576.00 | $141.44 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 808 | 1,362 | $476,700 | $122,614 | 25.7% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 124 | 1,963 | $166,855 | $68,435 | 41.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 161 | 192 | $139,200 | $35,150 | 25.3% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 124 | 453 | $79,275 | $31,595 | 39.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 33 | 180 | $135,000 | $26,648 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 132 | 132 | $59,400 | $14,274 | 24.0% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 23 | 23 | $80,500 | $12,662 | 15.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 147 | 257 | $66,725 | $11,612 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 179 | $43,855 | $9,899 | 22.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 174 | 326 | $61,506 | $8,874 | 14.4% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 44 | 230 | $20,700 | $8,044 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 54 | $27,000 | $6,687 | 24.8% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2022 | 124 | 151 | $12,835 | $5,264 | 41.0% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 124 | 151 | $12,835 | $5,264 | 41.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 244 | 285 | $28,500 | $5,181 | 18.2% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 24 | 24 | $19,200 | $4,526 | 23.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 11 | 78 | $6,480 | $3,852 | 59.4% |
| 52204 | Biopsy of bladder using an endoscope | Office | 2022 | 12 | 12 | $18,000 | $3,401 | 18.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 27 | 42 | $12,280 | $3,158 | 25.7% |
About Dr. Michael Corea, MD
Dr. Michael Corea, MD is a Urology healthcare provider based in Dedham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104813641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Corea, MD has received a total of $10,538 in payments from pharmaceutical and medical device companies, with $60.35 received in 2024. These payments were reported across 288 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,368).
As a Medicare-enrolled provider, Corea has provided services to 12,510 Medicare beneficiaries, totaling 21,618 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Dedham, MA
- Active Since 09/30/2005
- Last Updated 01/16/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1104813641
Products in Payments
- INTERSTIM (Device) $760.82
- SOLYX (Device) $745.44
- ALTIS (Device) $744.37
- UroLift (Device) $650.02
- AMS (Device) $564.49
- AXIS (Biological) $440.23
- ERLEADA (Drug) $427.02
- HARMONIC Product Family (Device) $393.31
- ADVANTAGE FIT (Device) $385.33
- MYRBETRIQ (Drug) $314.82
- UROLIFT (Device) $268.10
- XIAFLEX (Biological) $264.92
- XTANDI (Drug) $195.16
- GENERAL - KIDNEY STONE DISEASE (Device) $188.21
- GEMTESA (Drug) $172.23
- EVICEL (Biological) $144.43
- Mega Power (Device) $136.05
- UroLift System (Device) $134.72
- Axonics (Device) $134.28
- Endocare Cryocare System (Medical Supply) $131.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.